https://m2.mtmt.hu/ eng 2026-10-22 21:03 JournalArticle 36198272 VALIDATED true 0 false 2026-10-07T11:48:51.368+0000 2026-07-23T11:17:55.495+0000 2025-06-19T08:01:13.383+0000 true 10065463 Turek Márta /api/admin/10065463 Admin Márta Turek (KOKI admin 4) true 2026-07-31T07:08:22.871+0000 2025-07-29T12:08:56.078+0000 true 10062062 Gere Tamásné /api/admin/10062062 Admin Tamásné Gere (SE_KK_Admin5_GT, admin) true 10062062 2025-12-22T18:11:43.097+0000 true 521 Szuper Admin /api/admin/521 Admin Admin Szuper (admin) true Admin 10025544 /api/admin/10025544 Katalin Lévayné Deseő (MTMT Központi admin) Lévayné Deseő Katalin true 10025544 true 2026-05-20T07:50:20.098+0000 true false true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Article (Journal Article) 101 true 10000059 true 1 /api/category/1 Category Scientific true 1 Szabó, Dorottya true true /api/journal/3361 REVIEWED NEUROPHARMACOLOGY 0028-3908 1873-7064 true false 3361 false 3361 true 0028-3908 1873-7064 Journal FOREIGN 278 110566 110566 12 2025 Funding 2054241 /api/funding/2054241 Hungarian Brain Research Program(NAP2022-I-1/2022) false true Funding 2054243 /api/funding/2054243 Recovery and Resilience Facility of the European Union within the framework of Programme Szécheny...(RRF-2.3.1-21-2022-00011) false true Funding 2054244 /api/funding/2054244 Nemzeti Gyógyszerkutatási és Fejlesztési Laboratórium (PharmaLab)(RRF-2.3.1-21-2022-00015) Funder: NRDIO false true Funding 2054242 /api/funding/2054242 National Laboratory of Translational Neuroscience (TINL)(RRF-2.3.1-21-2022-00011) false true true true 2025 true true true false true false GOLD 2026-10-07 true https://doi.org/10.1016/j.neuropharm.2025.110566 1 0 1 1 0 1 1 0 1 1 1 1 1 1 0 0 1 1 1 1 0 4 4 Folyóiratcikk Journal Article 24 1 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2026 0 1 1 1 1 Q1 false 10082477,10008942,10052098 false false false 2025-06-24T09:32:25.621+0000 Doktori Iskola (SE); Molekuláris Farmakológia Kutatócsoport (HRN KOKI); Nemzeti Népegészségügyi és Gyógyszerészeti Központ 9 36 3 10 0 true 10025544 Language 10002 /api/language/10002 English Angol English true 2 true PersonAuthorship 126950112 /api/authorship/126950112 Szabó, Dorottya [Szabó, Dorottya (neurofarmakológia), author] Laboratory of Molecular Pharmacology; School of PhD Studies (SU) 1 0.1 true false false Author 10067769 /api/author/10067769 Dorottya Szabó (neurofarmakológia) Szabó Dorottya true true Szabó Dorottya true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126950113 /api/authorship/126950113 Tod, Pál* [Tod, Pál (Purinerg jelátvit...), author] Laboratory of Molecular Pharmacology 2 0.1 true false false Author 10054736 /api/author/10054736 Pál Tod (Purinerg jelátviteli rendszer a központi idegrendszerben) Tod Pál true 10054736 true Tod Pál true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126950114 /api/authorship/126950114 Maácz, Fruzsina [Maácz, Fruzsina (Neurofarmakológia), author] Laboratory of Molecular Pharmacology; School of PhD Studies (SU) 3 0.1 false false false Author 10090595 /api/author/10090595 Fruzsina Maácz (Neurofarmakológia) Maácz Fruzsina true true Maácz Fruzsina true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126950115 /api/authorship/126950115 Gölöncsér, Flóra [Gölöncsér, Flóra (idegtudományok), author] Laboratory of Molecular Pharmacology 4 0.1 false false false Author 10052098 /api/author/10052098 Flóra Gölöncsér (idegtudományok) Gölöncsér Flóra true 10052098 true Gölöncsér Flóra true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126950116 /api/authorship/126950116 Iring-Varga, Bernadett [Iring-Varga, Bernadett (funkcionális ideg...), author] Laboratory of Molecular Pharmacology; School of PhD Studies (SU) 5 0.1 false false false Author 10076833 /api/author/10076833 Bernadett Iring-Varga (funkcionális idegtudomány) Iring-Varga Bernadett true true Iring-Varga Bernadett true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126950117 /api/authorship/126950117 Török, Bibiána [Szocsics-Török, Bibiána (Biológus), author] Laboratory of Molecular Pharmacology 6 0.1 false false false Author 10066202 /api/author/10066202 Bibiána Szocsics-Török (Biológus) Szocsics-Török Bibiána true true Török Bibiána true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126950118 /api/authorship/126950118 Zsidei, Gyula 7 0.1 false false false Zsidei Gyula true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126950119 /api/authorship/126950119 Pályi, Bernadett [Pályi, Bernadett (virológia), author] National Center for Public Health and Pharmacy 8 0.1 false false false Author 10082477 /api/author/10082477 Bernadett Pályi (virológia) Pályi Bernadett true true Pályi Bernadett true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126950120 /api/authorship/126950120 Kis, Zoltán [Kis, Zoltán (Mikrobiológia, Vi...), author] National Center for Public Health and Pharmacy 9 0.1 false false false Author 10057266 /api/author/10057266 Zoltán Kis (Mikrobiológia, Virológia) Kis Zoltán true 10057266 true Kis Zoltán true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126950121 /api/authorship/126950121 Sperlágh, Beáta ✉ [Sperlágh, Beáta (Neurofarmakológia), author] Laboratory of Molecular Pharmacology; School of PhD Studies (SU) 10 0.1 false true true Author 10008942 /api/author/10008942 Beáta Sperlágh (Neurofarmakológia) Sperlágh Beáta true 10008942 true Sperlágh Beáta true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PublicationIdentifier 29498264 /api/publicationidentifier/29498264 DOI: 10.1016/j.neuropharm.2025.110566 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.1016/j.neuropharm.2025.110566 https://doi.org/10.1016/j.neuropharm.2025.110566 false true PublicationIdentifier 29563801 /api/publicationidentifier/29563801 WoS: 001517792500001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001517792500001 https://www.webofscience.com/wos/woscc/full-record/001517792500001 true true PublicationIdentifier 32686261 /api/publicationidentifier/32686261 REAL: 243218 SwordSource 36 /api/publicationsource/36 REAL PublicationSourceType 10007 /api/publicationsourcetype/10007 Repozitórium true true true REAL REAL https://real.mtak.hu/@@@ true true 36 true GOLD true 243218 https://real.mtak.hu/243218 false true PublicationIdentifier 29525139 /api/publicationidentifier/29525139 Scopus: 105008228844 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 105008228844 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105008228844 true true PublicationIdentifier 29525143 /api/publicationidentifier/29525143 PubMed: 40532786 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 40532786 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=40532786&dopt=Abstract true true SjrRating 11564041 /api/sjrrating/11564041 sjr:Q1 (2025) Scopus - Cellular and Molecular Neuroscience NEUROPHARMACOLOGY 0028-3908 1873-7064 22 0.24 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2804 /api/classificationexternal/2804 Scopus - Cellular and Molecular Neuroscience true 2804 true Q1 DIRECT true true Reference 66440703 /api/reference/66440703 1. Alves 2023: SARS-CoV-2 spike protein alters microglial purinergic signaling., Front. Immunol., 14, DOI: 10.3389/fimmu.2023.1158460 1 10.3389/fimmu.2023.1158460 false true Reference 66440704 /api/reference/66440704 2. Amruta 2022: Mouse adapted SARS-CoV-2 (MA10) viral infection induces neuroinflammation in standard laboratory mice., Viruses, 15, DOI: 10.3390/v15010114 2 10.3390/v15010114 false true Reference 66440705 /api/reference/66440705 3. Bhattacharya 2020: Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric disorders., Neuropsychopharmacology, 45, p. 234, DOI: 10.1038/s41386-019-0502-9 3 10.1038/s41386-019-0502-9 false true Reference 66440706 /api/reference/66440706 4. Bhattacharya 2016: Role of neuro-immunological factors in the pathophysiology of mood disorders., Psychopharmacology (Berl), 233, p. 1623, DOI: 10.1007/s00213-016-4214-0 4 10.1007/s00213-016-4214-0 false true Reference 66440707 /api/reference/66440707 5. Bhattacharya 2013: Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567., Br. J. Pharmacol., 170, p. 624, DOI: 10.1111/bph.12314 5 10.1111/bph.12314 false true Reference 66440708 /api/reference/66440708 6. Bidula 2019: Positive allosteric modulation of P2X7 promotes apoptotic cell death over lytic cell death responses in macrophages., Cell Death Dis., 10, p. 882, DOI: 10.1038/s41419-019-2110-3 6 10.1038/s41419-019-2110-3 false true Reference 66440709 /api/reference/66440709 7. Burnstock 2016: P2X ion channel receptors and inflammation., Purinergic Signal., 12, p. 59, DOI: 10.1007/s11302-015-9493-0 7 10.1007/s11302-015-9493-0 false true Reference 66440710 /api/reference/66440710 8. Chen 2007: Identification of a key pathway required for the Sterile inflammatory response triggered by dying cells., Nat. Med., 13, p. 851, DOI: 10.1038/nm1603 8 10.1038/nm1603 false true Reference 66440711 /api/reference/66440711 9. Chippa 2025: Postacute coronavirus (COVID-19) syndrome.StatPearls 9 false true Reference 66440712 /api/reference/66440712 10. Chu 2022: Animal models in SARS-CoV-2 research., Nat. Methods, 19, p. 392, DOI: 10.1038/s41592-022-01447-w 10 10.1038/s41592-022-01447-w false true Reference 66440713 /api/reference/66440713 11. Clark 1997: Monofilament intraluminal middle cerebral artery occlusion in the mouse., Neurol. Res., 19, p. 641, DOI: 10.1080/01616412.1997.11740874 11 10.1080/01616412.1997.11740874 false true Reference 66440714 /api/reference/66440714 12. Csölle 2013: Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors., PLoS One, 8, DOI: 10.1371/journal.pone.0066547 12 10.1371/journal.pone.0066547 false true Reference 66440715 /api/reference/66440715 13. D'Hondt 2024: Anxiety and depression in people with post-COVID condition: a Belgian population-based cohort study three months after SARS-CoV-2 infection., Soc. Psychiatr. Psychiatr. Epidemiol., 59, p. 2083, DOI: 10.1007/s00127-024-02655-9 13 10.1007/s00127-024-02655-9 false true Reference 66440716 /api/reference/66440716 14. Dai 2025: Animal models of post-acute COVID-19 syndrome: a call for longitudinal animal studies., Front. Immunol., 16, DOI: 10.3389/fimmu.2025.1521029 14 10.3389/fimmu.2025.1521029 false true Reference 66440717 /api/reference/66440717 15. Drayson 2023: A rigorous behavioral testing platform for the assessment of radiation-induced neurological outcomes., Methods Cell Biol., 180, p. 177, DOI: 10.1016/bs.mcb.2023.02.015 15 10.1016/bs.mcb.2023.02.015 false true Reference 66440718 /api/reference/66440718 16. Edouard Mathieu 16 false true Reference 66440719 /api/reference/66440719 17. Francis 2023: COVID-19 infection does not seem to affect cognition in college students., Conscious. Cognit., 108, DOI: 10.1016/j.concog.2023.103464 17 10.1016/j.concog.2023.103464 false true Reference 66440720 /api/reference/66440720 18. Frontera 2022: Bridging knowledge gaps in the diagnosis and management of neuropsychiatric sequelae of COVID-19., JAMA Psychiatry, 79, p. 811, DOI: 10.1001/jamapsychiatry.2022.1616 18 10.1001/jamapsychiatry.2022.1616 false true Reference 66440721 /api/reference/66440721 19. Ganesh 2024: Pro inflammatory cytokines profiles of patients with long COVID differ between variant epochs., Journal of Primary Care & Community Health, 15, DOI: 10.1177/21501319241254751 19 10.1177/21501319241254751 false true Reference 66440722 /api/reference/66440722 20. García-Villalba 2022: Soluble P2X7 receptor is elevated in the plasma of COVID-19 patients and correlates with disease severity., Front. Immunol., 13, DOI: 10.3389/fimmu.2022.894470 20 10.3389/fimmu.2022.894470 false true Reference 66440723 /api/reference/66440723 21. Hu 2017: Re-evaluation of the interrelationships among the behavioral tests in rats exposed to chronic unpredictable mild stress., PLoS One, 12, DOI: 10.1371/journal.pone.0185129 21 10.1371/journal.pone.0185129 false true Reference 66440724 /api/reference/66440724 22. Hu 2006: IFN-Gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins., Immunity, 24, p. 563, DOI: 10.1016/j.immuni.2006.02.014 22 10.1016/j.immuni.2006.02.014 false true Reference 66440725 /api/reference/66440725 23. Iqbal 2023: Post-COVID-19-associated multiorgan complications or "long COVID" with literature review and management strategy discussion: a meta-analysis., Health Sci. Rep., 6, DOI: 10.1002/hsr2.1211 23 10.1002/hsr2.1211 false true Reference 66440726 /api/reference/66440726 24. Jiang 2025: SARS-CoV-2 spike S1 protein induces microglial NLRP3-dependent neuroinflammation and cognitive impairment in mice., Exp. Neurol., 383, DOI: 10.1016/j.expneurol.2024.115020 24 10.1016/j.expneurol.2024.115020 false true Reference 66440727 /api/reference/66440727 25. Jiao 2024: Research progress of post-acute sequelae after SARS-CoV-2 infection., Cell Death Dis., 15, p. 257, DOI: 10.1038/s41419-024-06642-5 25 10.1038/s41419-024-06642-5 false true Reference 66440728 /api/reference/66440728 26. Klein 2021: COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis., Res Sq 26 false true Reference 66440729 /api/reference/66440729 27. Koványi 2016: The role of P2X7 receptors in a rodent PCP-Induced schizophrenia model., Sci. Rep., 6, DOI: 10.1038/srep36680 27 10.1038/srep36680 false true Reference 66440730 /api/reference/66440730 28. Lago 2017: Striatum on the anxiety map: small detours into adolescence., Brain Res., 1654, p. 177, DOI: 10.1016/j.brainres.2016.06.006 28 10.1016/j.brainres.2016.06.006 false true Reference 66440731 /api/reference/66440731 29. Lécuyer 2023: The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection., Front. Immunol., 14, DOI: 10.3389/fimmu.2023.1270081 29 10.3389/fimmu.2023.1270081 false true Reference 66440732 /api/reference/66440732 30. Leeson 2019: P2X7 receptor signaling during adult hippocampal neurogenesis., Neural Regen Res, 14, p. 1684, DOI: 10.4103/1673-5374.257510 30 10.4103/1673-5374.257510 false true Reference 66440733 /api/reference/66440733 31. Leist 2020: A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice., Cell, 183, p. 1070, DOI: 10.1016/j.cell.2020.09.050 31 10.1016/j.cell.2020.09.050 false true Reference 66440734 /api/reference/66440734 32. Li 2023: Emerging landscape of preclinical models for studying COVID-19 neurologic diseases., ACS Pharmacol. Transl. Sci., 6, p. 1323, DOI: 10.1021/acsptsci.3c00127 32 10.1021/acsptsci.3c00127 false true Reference 66440735 /api/reference/66440735 33. Miras-Portugal 2017: Neuronal P2X7 receptor: involvement in neuronal physiology and pathology., J. Neurosci., 37, p. 7063, DOI: 10.1523/JNEUROSCI.3104-16.2017 33 10.1523/JNEUROSCI.3104-16.2017 false true Reference 66440736 /api/reference/66440736 34. Monje 2022: The neurobiology of long COVID., Neuron, 110, p. 3484, DOI: 10.1016/j.neuron.2022.10.006 34 10.1016/j.neuron.2022.10.006 false true Reference 66440737 /api/reference/66440737 35. Motulsky 2006: Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate., BMC Bioinf., 7, p. 123, DOI: 10.1186/1471-2105-7-123 35 10.1186/1471-2105-7-123 false true Reference 66440738 /api/reference/66440738 36. Mukherjee 36 false true Reference 66440739 /api/reference/66440739 37. Nalbandian 2021: Post-acute COVID-19 syndrome., Nat. Med., 27, p. 601, DOI: 10.1038/s41591-021-01283-z 37 10.1038/s41591-021-01283-z false true Reference 66440740 /api/reference/66440740 38. Oh 2022: SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal death., Sci. Rep., 12, p. 5496, DOI: 10.1038/s41598-022-09410-7 38 10.1038/s41598-022-09410-7 false true Reference 66440741 /api/reference/66440741 39. Oladunni 2020: Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice., Nat. Commun., 11, p. 6122, DOI: 10.1038/s41467-020-19891-7 39 10.1038/s41467-020-19891-7 false true Reference 66440742 /api/reference/66440742 40. Oliveira-Giacomelli 2021: Role of P2X7 receptors in immune responses during neurodegeneration., Front. Cell. Neurosci., 15, DOI: 10.3389/fncel.2021.662935 40 10.3389/fncel.2021.662935 false true Reference 66440743 /api/reference/66440743 41. Oliveira 2016: Purinergic receptors in embryonic and adult neurogenesis., Neuropharmacology, 104, p. 272, DOI: 10.1016/j.neuropharm.2015.10.008 41 10.1016/j.neuropharm.2015.10.008 false true Reference 66440744 /api/reference/66440744 42. Organization 42 false true Reference 66440745 /api/reference/66440745 43. Pacheco 2021: The potential involvement of P2X7 receptor in COVID-19 pathogenesis: a new therapeutic target?., Scand. J. Immunol., 93, DOI: 10.1111/sji.12960 43 10.1111/sji.12960 false true Reference 66440746 /api/reference/66440746 44. Queiroz 2022: Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome., Front. Cell. Infect. Microbiol., 12, DOI: 10.3389/fcimb.2022.922422 44 10.3389/fcimb.2022.922422 false true Reference 66440747 /api/reference/66440747 45. Ribeiro 2021: Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology., Mol. Psychiatr., 26, p. 1044, DOI: 10.1038/s41380-020-00965-3 45 10.1038/s41380-020-00965-3 false true Reference 66440748 /api/reference/66440748 46. Rider 2011: IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation., J. Immunol., 187, p. 4835, DOI: 10.4049/jimmunol.1102048 46 10.4049/jimmunol.1102048 false true Reference 66440749 /api/reference/66440749 47. Ruiz-Rodríguez 2020: Chemoresistance in breast cancer patients associated with changes in P2X7 and A2A purinergic receptors in CD8(+) T lymphocytes., Front. Pharmacol., 11, DOI: 10.3389/fphar.2020.576955 47 10.3389/fphar.2020.576955 false true Reference 66440750 /api/reference/66440750 48. Saraiva 2010: The regulation of IL-10 production by immune cells., Nat. Rev. Immunol., 10, p. 170, DOI: 10.1038/nri2711 48 10.1038/nri2711 false true Reference 66440751 /api/reference/66440751 49. Shibata 1998: Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-Gamma., J. Immunol., 161, p. 4283, DOI: 10.4049/jimmunol.161.8.4283 49 10.4049/jimmunol.161.8.4283 false true Reference 66440752 /api/reference/66440752 50. Singh 2024: A murine model of post-acute neurological sequelae following SARS-CoV-2 variant infection., Front. Immunol., 15, DOI: 10.3389/fimmu.2024.1384516 50 10.3389/fimmu.2024.1384516 false true Reference 66440753 /api/reference/66440753 51. Sperlágh 2014: P2X7 receptor: an emerging target in central nervous system diseases., Trends Pharmacol. Sci., 35, p. 537, DOI: 10.1016/j.tips.2014.08.002 51 10.1016/j.tips.2014.08.002 false true Reference 66440754 /api/reference/66440754 52. Sriram 52 false true Reference 66440755 /api/reference/66440755 53. Szabó 2022: Maternal P2X7 receptor inhibition prevents autism-like phenotype in Male mouse offspring through the NLRP3-IL-1β pathway., Brain Behav. Immun., 101, p. 318, DOI: 10.1016/j.bbi.2022.01.015 53 10.1016/j.bbi.2022.01.015 false true Reference 66440756 /api/reference/66440756 54. Takao 2023: Neurological post-acute sequelae of SARS-CoV-2 infection., Psychiatr. Clin. Neurosci., 77, p. 72, DOI: 10.1111/pcn.13481 54 10.1111/pcn.13481 false true Reference 66440757 /api/reference/66440757 55. Vultaggio-Poma 2023: The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients., Front. Immunol., 14, DOI: 10.3389/fimmu.2023.1182454 55 10.3389/fimmu.2023.1182454 false true Reference 66440758 /api/reference/66440758 56. Wild 2022: Disentangling the cognitive, physical, and mental health sequelae of COVID-19., Cell Rep. Med., 3 56 false true Reference 66440759 /api/reference/66440759 57. Yin 2024: Chapter 7 - interleukin-1 beta in psychosocial stress.Stress: Immunology and Inflammation, p. 53 57 false true Reference 66440760 /api/reference/66440760 58. Zeng 2023: A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action., Mol. Psychiatr., 28, p. 423, DOI: 10.1038/s41380-022-01614-7 58 10.1038/s41380-022-01614-7 false true Reference 66440761 /api/reference/66440761 59. Zhang 2021: SARS-CoV-2 crosses the blood–brain barrier accompanied with basement membrane disruption without tight junctions alteration., Signal Transduct. Targeted Ther., 6, p. 337, DOI: 10.1038/s41392-021-00719-9 59 10.1038/s41392-021-00719-9 false true /api/publication/36198272 Szabó Dorottya et al. Targeting P2X7 mitigates neurobehavioural alterations in a mouse model of post-acute sequelae of SARS-CoV-2 infection. (2025) NEUROPHARMACOLOGY 0028-3908 1873-7064 278<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10067769"><a href="/gui2/?type=authors&mode=browse&sel=10067769" target="_blank">Szabó Dorottya (<span class="authorship-author-name">Szabó Dorottya</span> <span class="authorAux-mtmt"> neurofarmakológia</span>) </a> </span> <span class="author-affil"><span title="HUN-REN Institute of Experimental Medicine">HUN-REN IEM</span>/Laboratory of Molecular Pharmacology; <span title="Semmelweis University">SU</span>/School of PhD Studies</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10054736"><a href="/gui2/?type=authors&mode=browse&sel=10054736" target="_blank">Tod Pál^* (<span class="authorship-author-name">Tod Pál</span> <span class="authorAux-mtmt"> Purinerg jelátviteli rendszer a központi idegre...</span>) </a> </span> <span class="author-affil"><span title="HUN-REN Institute of Experimental Medicine">HUN-REN IEM</span>/Laboratory of Molecular Pharmacology</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10090595"><a href="/gui2/?type=authors&mode=browse&sel=10090595" target="_blank">Maácz Fruzsina (<span class="authorship-author-name">Maácz Fruzsina</span> <span class="authorAux-mtmt"> Neurofarmakológia</span>) </a> </span> <span class="author-affil"><span title="HUN-REN Institute of Experimental Medicine">HUN-REN IEM</span>/Laboratory of Molecular Pharmacology; <span title="Semmelweis University">SU</span>/School of PhD Studies</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10052098"><a href="/gui2/?type=authors&mode=browse&sel=10052098" target="_blank">Gölöncsér Flóra (<span class="authorship-author-name">Gölöncsér Flóra</span> <span class="authorAux-mtmt"> idegtudományok</span>) </a> </span> <span class="author-affil"><span title="HUN-REN Institute of Experimental Medicine">HUN-REN IEM</span>/Laboratory of Molecular Pharmacology</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10076833"><a href="/gui2/?type=authors&mode=browse&sel=10076833" target="_blank">Iring-Varga Bernadett (<span class="authorship-author-name">Iring-Varga Bernadett</span> <span class="authorAux-mtmt"> funkcionális idegtudomány</span>) </a> </span> <span class="author-affil"><span title="HUN-REN Institute of Experimental Medicine">HUN-REN IEM</span>/Laboratory of Molecular Pharmacology; <span title="Semmelweis University">SU</span>/School of PhD Studies</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10066202"><a href="/gui2/?type=authors&mode=browse&sel=10066202" target="_blank">Török Bibiána (<span class="authorship-author-name">Szocsics-Török Bibiána</span> <span class="authorAux-mtmt"> Biológus</span>) </a> </span> <span class="author-affil"><span title="HUN-REN Institute of Experimental Medicine">HUN-REN IEM</span>/Laboratory of Molecular Pharmacology</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Zsidei Gyula </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10082477"><a href="/gui2/?type=authors&mode=browse&sel=10082477" target="_blank">Pályi Bernadett (<span class="authorship-author-name">Pályi Bernadett</span> <span class="authorAux-mtmt"> virológia</span>) </a> </span> <span class="author-affil">National Center for Public Health and Pharmacy</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10057266"><a href="/gui2/?type=authors&mode=browse&sel=10057266" target="_blank">Kis Zoltán (<span class="authorship-author-name">Kis Zoltán</span> <span class="authorAux-mtmt"> Mikrobiológia, Virológia</span>) </a> </span> <span class="author-affil">National Center for Public Health and Pharmacy</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10008942"><a href="/gui2/?type=authors&mode=browse&sel=10008942" target="_blank">Sperlágh Beáta ✉ (<span class="authorship-author-name">Sperlágh Beáta</span> <span class="authorAux-mtmt"> Neurofarmakológia</span>) </a> </span> <span class="author-affil"><span title="HUN-REN Institute of Experimental Medicine">HUN-REN IEM</span>/Laboratory of Molecular Pharmacology; <span title="Semmelweis University">SU</span>/School of PhD Studies</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;36198272" target="_blank">Targeting P2X7 mitigates neurobehavioural alterations in a mouse model of post-acute sequelae of SARS-CoV-2 infection</a></div> <div> <span class="journal-title">NEUROPHARMACOLOGY</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/0028-3908">0028-3908</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1873-7064">1873-7064</a>)</span>: <span class="journal-volume">278</span> <span class="page"> Paper 110566. 12 p. </span> <span class="year">(2025)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Language: English | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.1016/j.neuropharm.2025.110566" target="_blank" href="https://doi.org/10.1016/j.neuropharm.2025.110566"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001517792500001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001517792500001"> WoS </a> </span> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:black" title="243218" target="_blank" href="https://real.mtak.hu/243218"> REAL </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="105008228844" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105008228844"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="40532786" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=40532786&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Journal subject: Scopus - Cellular and Molecular Neuroscience&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> <div class="journal-subject">Journal subject: Scopus - Pharmacology&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="" class="citingPub-count">Citing papers: 1</span> | Independent citation: 1 | Self citation: 0 | Unknown citation: 0 | Number of citations in Scopus:&nbsp;1 | WoS/Scopus assigned:&nbsp;1 | Number of citations with DOI:&nbsp;1 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;36198272&sort=publishedYear,desc&sort=title"> Number of cited publications: 4 </a> </div> <div class="mtid"><span class="long-pub-mtid">Publication: 36198272</span> | <span class="status-data status-VALIDATED"> Validated </span> Core Citing | <span class="type-subtype">Journal Article ( Article ) </span> | <span class="pub-category">Scientific</span> | <span class="publication-sourceOfData">Scopus</span> </div> <div class="funder"> Hungarian Brain Research Program(NAP2022-I-1/2022), Recovery and Resilience Facility of the European Union within the framework of Programme Szécheny...(RRF-2.3.1-21-2022-00011), Nemzeti Gyógyszerkutatási és Fejlesztési Laboratórium (PharmaLab)(RRF-2.3.1-21-2022-00015) Funder: NRDIO, National Laboratory of Translational Neuroscience (TINL)(RRF-2.3.1-21-2022-00011) </div> <div class="lastModified">Last Modified: 2026.07.23. 13:17 Ildikó Balázsné Balogh (NNGYK 4 admin) </div> <div class="lockedBy">Centrally managed 2026.05.20. 09:50 Katalin Lévayné Deseő (MTMT Központi admin) </div> </div></div>